ELTX (Elicio Therapeutics) FFO


ELTX Elicio Therapeutics Inc ELTX
32 GF Score
Price $3.99
! 1 Warning Sign
View Full Analysis

What is Elicio Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

ELTX
32GF Score
Elicio Therapeutics Inc ELTX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elicio Therapeutics Business Description

Other Exchanges 9HA:Germany
Address 451 D Street, Suite 501, 5th Floor, Boston, MA, USA, 02210
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
32GF Score

Get the complete analysis for ELTX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.99
Price